GeneBio Systems
Recombinant CLEC2D Monoclonal Antibody
Recombinant CLEC2D Monoclonal Antibody
SKU:AN301970L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:CLEC2D
Target Synonym:LLT;CLEC2D;CLAX;LLT1;OCIL;C type lectin related f;C type lectin superfamily 2;CLC2D;CLEC2D protein;Clec2d5;C-type lectin domain family 2 member D;L LT1;Lectin like NK cell receptor;Lectin like transcript 1;Lectin-like NK cell receptor;Lectin-like transcript 1;LLT-1;member D;Osteoclast inhibitory lectin
Research Areas:Immunology
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;
Application:WB
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A686
UNIProt ID:Q9UHP7
Accession:
Background:C-type lectin domain family 2 member D (CLEC2D), also known as lectin-like transcript 1 (LLT1) and osteoclast inhibitory lectin (OCIL), is a type II transmembrane C-type lectin receptor primarily expressed upon immune cell activation in T cells, B cells, NK cells, and plasmacytoid and monocyte-derived dendritic cells. CLEC2D interacts with NKR-P1A (KLRB1, CD161) on NK cells and some subsets of T cells, inhibiting NK cell cytotoxicity while alternatively inducing proliferation and IFNγ production in T cells. CLEC2D is also expressed by osteoblasts, inhibiting osteoclast formation and bone resorption.
Concentration:1 mg/mL
Immunogen:Recombinant human CLEC2D fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:500-1:1000
Calculated MW:22 kDa
ObservedMW:25-35 kDa
